Drug recall · June 5, 2013
Lisinopril Tablets recall
Why: Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India
- Lots / codes
Lot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13
- Quantity
- 1776 bottles
- Company
- Aurobindo Pharma USA Inc, Plainsboro, NJ
- Distribution
- Nationwide
- Initiated
- April 9, 2013 · Voluntary: Firm initiated
- Classified
- May 30, 2013
- Reported
- June 5, 2013
- Ended
- January 23, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lisinopril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.